Coming Soon!
Emerging Firms
Accounting Firms
Banks, Insurance
Real Estate Developers
Hospitals
Hotels & Restaurants
Media
Arts Leaders
Science Leaders
Government and Politics
       |
   
     
|
Venture Capital Firms and Investment Banks J-P
| Johnson & Johnson Development Corporation |
| One Johnson & Johnson Plaza |
| New Brunswick, NJ 08933 |
| Phone: (732) 524-3637 |
| Larry Pickering |
| President |
| Wholly-owned subsidiary of JOHNSON & JOHNSON> Invests venture capital in start-up, later stage and acquisition of health-care firms> Preferred investments minority equity positions where control remains with original management> No minimum criteria, investments range from $14,000 to $30 million> Tailors investment deal to needs of portfolio companies. |
| Johnston Associates |
| 181 Cherry Valley Road |
| Princeton, NJ 08540 |
| Phone: (609) 924-3131 |
| Fax: (609) 683-7524 |
| Robert F. Johnston |
| President |
| Founded 1968 by Robert Johnston> Seed venture capital and investment banking firm with focus on biotechnology and health care investments> Preferred investments are $1 million in deal origination in medical technology and genetic engineering> NJ investments include CYTOGEN, (Princeton, biotechnology firm which Robert Johnston serves as chairman); other investments include I-Stat, Immunicon, Biolyte Genex Corp. (protein products), Spex Group (scientific instruments), Ecogen (microbial genetics), Sepracor (membrane separation technology), ENVIROGEN (microbe degradation of toxic waste)> Also invests in leveraged buyouts, and acts as investment banker in mergers, acquisitions, divestitures, and restructuring> CEO Robert Johnston previously investment banker with F.S. Smithers & Co. and Smith Barney B.A. PRINCETON UNIVERSITY, M.B.A., New York University; other principals include Robert B. Stockman, previously investment analyst with Narraganset Capital and accountant with Price Waterhouse, M.B.A. Amos Tuck School at Dartmouth College, B.A. Harvard; Richard G. Horan, previously with Bank of America, Continental Illinois Bank, M.B.A. Amos Tuck School at Dartmouth College, B.A. Dartmouth College. |
| Knickerbocker LLC |
| 268 Main Street |
| PO Box 159 |
| Gladstone, NJ 07934 |
| Phone: (908) 719-6724 |
| Fax: (908) 719-6725 |
| e-mail: info@knickerbockerllc.com |
| Web Site: http://www.knickerbockerllc.com |
| Finn M. W. Caspersen CEO |
| Private investment management firm overseeing accounting and investments of various trusts, foundations and individuals> chairman of Westby Corporation, a privately held agricultural conglomerate. Headed by FINN M. W. CASPERSEN, former chairman and CEO of Beneficial Corporation from 1976 to 1998 when Beneficial merged into Household International, active political contributor for George W. Bush, BOB FRANKS, CHRISTINE TODD WHITMAN ,past chairman of NJ Transportation Trust Fund and past co-chairman of Prosperity NJ and current chairman of NJ Ellis Island Commission> Gustav Koven, former president of CHASE MANHATTAN Capital, serves as adviser on venture and equity investments> Investments include AuthenTec, FL-based firm developing personal identication technology; Softrax, MA-based provider of operational and financial management applications for software companies. |
| MBW Venture Partners |
| 365 South Street |
| Morristown, NJ 07960 |
| Phone: (973) 285-5533 |
| Fax: (973) 295-5108 |
| Philip E. McCarthy Managing Director |
| Founded 1984, over $100 million capital under management, invests in diverse growth industries but with focus on health care, medical products, biotechnology buyouts, telecommunications, computer, electronics at all stages of development, including seed financings and management> Prefers to initiate or be lead investor, with typical initial investment $1-3 million> NJ Managing Partner Philip McCarthy previously vice president of Inco Ltd., co-founder of several biotechnology companies, served as director LIPOSOME CO. (Princeton), other biotechnology firms, J.D., B.S. Cornell University. |
| MidMark Capital |
| 466 Southern Boulevard |
| Chatham, NJ 07928 |
| Phone: (973) 822-2999 |
| Fax: (973) 822-8911 |
| Web Site: http://www.midmarkcapital.com |
| Wayne Clevenger Managing Director |
| Venture capital and investments in stand-alone middle market compnies, primarily privately-held or spin-offs from larger firms with revenues in range of $20 million to $150 million with valuations between $20 million to $100 million> Prefers to be lead investor and retain majority ownership together with management> Preferred industries manufacturing, systems assembly, distribution, service or retail, avoids business sectors with high, rapidly changing technology> Wayne Clevenger former president of Lexington Investment Co. 1985-89, previously at DLJ Capital Corp. (Donaldson, Lufkin & Jenrette) and Inco Securities Corp., also former plant manager for Inco Limited, overseeing 500-employee, $50 million industrial battery operation, MBA Columbia University, B.A. Case Western Reserve University; Denis Newman previously employed for 33 years at First Boston Corp., including 21 as a managing director, founded and managed First Boston Investment Group 1981-86, and also headed International Group, involved in over 200 public offerings and private placements, M.B.A. Harvard Business School, B.A. Yale University; Joseph R. Robinson previously vice president of Lexington Investment Co., also with Vendex International, SHV Holdings and International Basic Economy Corp., with extensive management experience in Latin America and in turnaround and divestment situations, attended Wharton School of Finance, B.A. Cornell University. |
| Monmouth Capital Corporation |
| 3499 Route 9 North |
| Freehold, NJ 07728 |
| Phone: (732) 577-9997 |
| Fax: (732) 577-9980 |
| Eugene W. Landy President |
| Preferred investments firms with average pre-tax earnings below $500,000, net worth under $5 million, assets under $10 million> Financing secured by commercial real estate, investment limit $500,000> Primarily mortgage lender, some equity investments in publishing, apparel manufacturers. |
| Nassau Capital |
| 22 Chambers Street |
| Princeton, NJ 08542 |
| Phone: (609) 924-3555 |
| Fax: (609) 924-8887 |
| e-mail: nmadden@nassau.com |
| Web Site: http://www.nassau.com |
| Randall A. Hack Senior Managing Director |
| Invests in private companies and assets on behalf of PRINCETON UNIVERSITY $6.3 billion endowment fund> Established 1994 to succeed Princeton University Investment Company in-house investment operation, maintains exclusive relationship with Princeton, currently manages $2 billion portfolio of private equity and real estate investments> Invested since 1995 over $300 million in over two dozen companies and real estate situations with particular interest in the communications and health care services industries> Originates and leads buyouts, provides growth equity, and selectively invests in venture situations and real estate opportunities, invests in wide range of transactions and industries, also coinvests in transactions sponsored by others> Transaction types include management buyouts; growth capital for expansion and strategic repositioning; corporate divestitures; investment in family-owned businesses to provide liquidity or facilitate a management transition; joint acquisitions with corporate partners; recapitalizations of fundamentally sound companies burdened by excessive debt; selective investments in early-stage venture capital deals; selective investments in real estate projects and operating companies> Investment preferences in firms valued $25 million to $250 million with investments ranging $10 million to $30 million> Portfolio companies include InterLink Communications (operator of cable television systems located in suburban and rural markets); KMC Telecom (Competitive Local Exchange Carrier provides local telecommunication services as alternative to incumbent local exchange companies); LiveWire (develops and markets wireless billing software to cellular telephone industry); Petersen Publishing Company (leading provider of special interest magazines including Motor Trend, Hot Rod, and Teen); AMERIGROUP (HMO founded 1994 to provide Medicaid and Medicare recipients with managed health care operates managed care plans in NJ, IL, and TX); CompHealth (subsidiary of HEALTHSOUTH Corp., nation's leading provider of temporary placement services for physicians and therapists); Concentra (formed 1997 through merger of two largest publicly-traded companies focused on occupational healthcare and managed care services for workers' compensation) Founding members include Randall A. Hack, 1990-1994 served as President and CEO of Princeton University Investment Company with overall management responsibility for Princeton's multi-billion portfolio of public and private assets; 1988-1990 President and CEO of Capstone Equities, Inc.; and 1979-1988 Founder, President and CEO of MATRIX DEVELOPMENT COMPANY, commercial and industrial real estate development firm; graduate of Princeton (B.A., summa cum laude, 1969) and Harvard (M.B.A., 1972); serves as Director of OmniCell Technologies, Inc., SweetWater, Inc., Asean Strategic Capital (Singapore), APAC Holdings Limited (Hong Kong) and Mezzanine Capital Property Investors> John G. Quigley, broad background in private equity investing, with experience since 1980 as a founding member of Clipper Capital Partners; partner of Adler & Shaykin; and attorney with Kirkland & Ellis in Chicago; director of companies in a variety of businesses, including specialty retailing, environmental equipment, underground coal mining machinery and newspaper publishing; graduate of Georgetown (A.B., summa cum laude, 1976), Stanford (J.D., M.B.A., 1980; Baker Scholar) and Columbia (M.Phil., 1992), adjunct faculty member in Finance department at New York University's Stern School of Business. |
| Penny Lane Partners |
| 1 Palmer Square |
| Suite 309 |
| Princeton, NJ 08542 |
| Phone: (609) 497-4646 |
| Fax: (609) 497-0611 |
| Stephen H. Shaffer Managing Partner |
| Venture capital firm
with $30 million under management, also licensed small business investment
company> Preferred investment size: $1 to $2 million in expansion,
later stage, and buyouts in diversified industries> Investments include
CommerceInc., (Internet company that hosts and builds free web sites for
small businesses); Outlast Technologies (distribution/retailing of thermal
regulating fabrics and fibers). |
| ProQuest Investments, L.P. |
| 1 Palmer Square |
| Princeton, NJ 08542 |
| Phone: (609) 430-1560 |
| Fax: (609) 430-1127 |
| Web Site: http://www.proquestinvestments.com |
| Sponsored by DOMAIN ASSOCIATES, makes equity investments in private and small public healthcare companies focused on treatment of cancer in general and prostate cancer in particular> Focus on specific disease designed to take advantage of attractive investment opportunities in market with significant unmet needs through extensive contacts and relevant expertise of its managers and advisors> Successfully completed initial May 1999 fund raising, on aggregate capital commitments of $100 million from leading institutional and individual investors> Invests in cancer-related companies focused on developing new commercial products and services, including: biotechnology, pharmaceutical, medical devices, clinical information and healthcare services> Investment stages ranging from early stage through fully commercialized companies, taking active role in management of portfolio companies, expertise of its managers and advisors to establish strategic partnerships and to raise additional funds necessary for commercial development> Partners include Jay Moorin, previously served as CEO of Magainin Pharmaceuticals. a venture-backed biotechnology company which raised over $150 million in private and public capital, also prior positions at Bear Stearns, Squibb; Jeremy Goldberg, entrepreneur with transactional experience as founder of several healthcare companies, consultant to venture capital fund and in operating positions at SmithKline Beecham and BECTON DICKINSON; Dr. Alain Schreiber served as CEO of Vical Inc. venture-backed biotechnology company which raised over $200 million in private and public capital, developed novel technology for vaccines, also previously senior vice president research at Rhone-Poulenc Rorer (now AVENTIS) |
| Prudential Capital Group |
| 751 Broad Street |
| Newark, NJ 07102 |
| Phone: (973) 802-6000 |
| Mendel Melzer |
| President & CEO |
| Subsidiary of PRUDENTIAL INSURANCE CO. which manages over $200 billion in capital> Various units invest in nearly all markets, including venture capital, real estate, corporate finance in public and private debt equity securities> Operates through 27 business units> Also acts as asset manager for other institutions, pension funds, banks. |
| Go to Venture Capital A-C | Go to Venture Capital D-I | Go to Venture Capital J-R | Go to Venture Capital S-Z |
JOSHUA
//
Communications, Inc.
|
Copyright © 2000 Joshua Communications, Inc.